Pat Killingsworth Pat Killingsworth

Helpful summary of new proteasome inhibitor anti-myeloma agents in the research pipeline

Here is a link to an excellent Myeloma Beacon review/summary which compares different experimental proteasome inhibitors Marizomib (NPI-0052) and MLN9708 with Velcade and carfilzomib:

Marizomib May Be Effective In Relapsed / Refractory Multiple Myeloma (ASH 2011)

Hopefully, each of these three new agents will help a number of patients who have become refractory to Velcade someday soon.

Feel good and keep smiling!  Pat